๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

DFMO: Targeted risk reduction therapy for colorectal neoplasia

โœ Scribed by Christina M. Laukaitis; Eugene W. Gerner

Book ID
116325813
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
346 KB
Volume
25
Category
Article
ISSN
1521-6918

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Faecal occult blood screening for colore
Faecal occult blood screening for colorectal neoplasia in a targeted high-risk population
โœ Mrs. S. M. Caffarey; C. I. M. Broughton; C. G. Marks ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 256 KB ๐Ÿ‘ 2 views

## colorectal neoplasia in a targeted high-risk population A general practice-based programme was initiated in I987 to identifv individuals at high risk of developing large bowel cancer and ofler them screening of faecal occult blood. In all, 5298 people from 21 general practices in the Guildford

Genetic syndromes as potential targets f
Genetic syndromes as potential targets for chemoprevention of colorectal neoplasia
โœ Bernard Levin ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 68 KB ๐Ÿ‘ 2 views

Colorectal cancer is the second leading cause of cancer death in the United States (Landis et al. [1998] CA 48:6-29) and is the most common cancer in Israel (Muir et al. [1997] International Agency for Research on Cancer, Lyon, France). In the United States, it is estimated that 130,000 individuals